Cargando…

Induced Pluripotent Stem Cells (iPSCs)—Roles in Regenerative Therapies, Disease Modelling and Drug Screening

The discovery of induced pluripotent stem cells (iPSCs) has made an invaluable contribution to the field of regenerative medicine, paving way for identifying the true potential of human embryonic stem cells (ESCs). Since the controversy around ethicality of ESCs continue to be debated, iPSCs have be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aboul-Soud, Mourad A. M., Alzahrani, Alhusain J., Mahmoud, Amer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467501/ https://www.ncbi.nlm.nih.gov/pubmed/34571968 http://dx.doi.org/10.3390/cells10092319

Ejemplares similares

Donor information in research and drug evaluation with induced pluripotent stem cells (iPSCs)
por: Orzechowski, Marcin, et al.
Publicado: (2020)

Research and therapy with induced pluripotent stem cells (iPSCs): social, legal, and ethical considerations
por: Moradi, Sharif, et al.
Publicado: (2019)

Epigenetic Modifiers Facilitate Induction and Pluripotency of Porcine iPSCs
por: Mao, Jian, et al.
Publicado: (2016)

Apoptosis in Porcine Pluripotent Cells: From ICM to iPSCs
por: Kim, Eunhye, et al.
Publicado: (2016)

Lucky iPSCs
por: Zviran, Asaf, et al.
Publicado: (2014)

iPSCs are safe!
por: Yan, Hualong, et al.
Publicado: (2017)

Versatility of Induced Pluripotent Stem Cells (iPSCs) for Improving the Knowledge on Musculoskeletal Diseases
por: Sanjurjo-Rodríguez, Clara, et al.
Publicado: (2020)

iPSCs in Modeling and Therapy of Osteoarthritis
por: Csobonyeiova, Maria, et al.
Publicado: (2021)

Reprogramming efficiency and pluripotency of mule iPSCs over its parents
por: Zhang, Jia, et al.
Publicado: (2023)

Decoding variants in drug-metabolizing enzymes and transporters in solid tumor patients by whole-exome sequencing
por: Aboul-Soud, Mourad A.M., et al.
Publicado: (2021)

Induced Pluripotent Stem Cells (iPSCs) and Gene Therapy: A New Era for the Treatment of Neurological Diseases
por: Paolini Sguazzi, Giulia, et al.
Publicado: (2021)

Utilizing induced pluripotent stem cells (iPSCs) to understand the actions of estrogens in human neurons
por: Shum, Carole, et al.
Publicado: (2015)

 Potential of Gene Editing and Induced Pluripotent Stem Cells (iPSCs) in Treatment of Retinal Diseases 
por: Chuang, Katherine, et al.
Publicado: (2017)

Content and Method of Information for Participants in Clinical Studies With Induced Pluripotent Stem Cells (iPSCs)
por: Orzechowski, Marcin, et al.
Publicado: (2021)

Differentiation of Human Induced Pluripotent Stem Cells (iPSCs)–derived Mesenchymal Progenitors into Chondrocytes
por: Khan, Nazir M., et al.
Publicado: (2023)

Patient-Derived Induced Pluripotent Stem Cells (iPSCs) and Cerebral Organoids for Drug Screening and Development in Autism Spectrum Disorder: Opportunities and Challenges
por: Villa, Chiara, et al.
Publicado: (2021)

iPSCs as a Platform for Disease Modeling, Drug Screening, and Personalized Therapy in Muscular Dystrophies
por: Ortiz-Vitali, Jose L., et al.
Publicado: (2019)

Differentiation of Mouse Induced Pluripotent Stem Cells (iPSCs) into Nucleus Pulposus-Like Cells In Vitro
por: Chen, Jun, et al.
Publicado: (2013)

Potential of Induced Pluripotent Stem Cells (iPSCs) for Treating Age-Related Macular Degeneration (AMD)
por: Fields, Mark, et al.
Publicado: (2016)

Senescence-associated ultrastructural features of long-term cultures of induced pluripotent stem cells (iPSCs)
por: Colasuonno, Fiorella, et al.
Publicado: (2017)

Induced Pluripotent Stem Cells (iPSCs) in Vascular Research: from Two- to Three-Dimensional Organoids
por: Trillhaase, Anja, et al.
Publicado: (2021)

The gene expression profiles of induced pluripotent stem cells (iPSCs) generated by a non-integrating method are more similar to embryonic stem cells than those of iPSCs generated by an integrating method
por: Liu, Yajun, et al.
Publicado: (2012)

Targeted Integration of Inducible Caspase-9 in Human iPSCs Allows Efficient in vitro Clearance of iPSCs and iPSC-Macrophages
por: Lipus, Alexandra, et al.
Publicado: (2020)

Clinical Therapy Using iPSCs: Hopes and Challenges
por: Lu, Xiao, et al.
Publicado: (2013)

Mitochondria fingerprint longevity in iPSCs
por: Masotti, Andrea, et al.
Publicado: (2015)

Applications of iPSCs in Cancer Research
por: Kim, Jean J
Publicado: (2015)

Reducing genomic instability in iPSCs
por: Ruiz, Sergio, et al.
Publicado: (2015)

The Challenge of Bringing iPSCs to the Patient
por: Ortuño-Costela, María del Carmen, et al.
Publicado: (2019)

Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer’s disease
por: Marei, Hany E., et al.
Publicado: (2023)

Combined Noncoding RNA-mRNA Regulomics Signature in Reprogramming and Pluripotency in iPSCs
por: Salloum-Asfar, Salam, et al.
Publicado: (2022)

Aged induced pluripotent stem cell (iPSCs) as a new cellular model for studying premature aging
por: Petrini, Stefania, et al.
Publicado: (2017)

Generation of 10 patient-specific induced pluripotent stem cells (iPSCs) to model Pitt-Hopkins Syndrome
por: Sripathy, S.R., et al.
Publicado: (2020)

Establishment and characterization of induced pluripotent stem cells (iPSCs) from central nervous system lupus erythematosus
por: De Angelis, Maria Teresa, et al.
Publicado: (2019)

Stimulation of Osteogenic Differentiation of Induced Pluripotent Stem Cells (iPSCs) Using Bioactive Glasses: An in vitro Study
por: Kargozar, Saeid, et al.
Publicado: (2019)

Decoding Genetics of Congenital Heart Disease Using Patient-Derived Induced Pluripotent Stem Cells (iPSCs)
por: Lin, Hui, et al.
Publicado: (2021)

Generation of 3D Skin Equivalents Fully Reconstituted from Human Induced Pluripotent Stem Cells (iPSCs)
por: Itoh, Munenari, et al.
Publicado: (2013)

Generation and characterization of human induced pluripotent stem cells (iPSCs) from hand osteoarthritis patient-derived fibroblasts
por: Castro-Viñuelas, R., et al.
Publicado: (2020)

Modeling Blast Crisis Using Mutagenized Chronic Myeloid Leukemia-Derived Induced Pluripotent Stem Cells (iPSCs)
por: Imeri, Jusuf, et al.
Publicado: (2023)

Pkm2 can enhance pluripotency in ESCs and promote somatic cell reprogramming to iPSCs
por: Qin, Shengtang, et al.
Publicado: (2017)

Studying leukemia stem cell properties and vulnerabilities with human iPSCs
por: Spyrou, Nikolaos, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ng3d06alavf7n11i0lhjckut7m